Meeting of the Uniform Formulary Beneficiary Advisory Panel, 22523-22524 [2013-08859]

Download as PDF Federal Register / Vol. 78, No. 73 / Tuesday, April 16, 2013 / Notices AUTHORITY FOR MAINTENANCE OF THE SYSTEM: Information maintained in the Biometric Verification System is collected pursuant to the National Capital Revitalization and SelfGovernment Improvement Act of 1997 (the Act), Public Law 105–33, DC Official Code § 24–133. The Act grants CSOSA the authority to supervise District of Columbia individuals on probation, parole, and supervised release. PURPOSE(S): The Biometric Verification System and use of biometric hand readers at CSOSA allows individuals under CSOSA supervision to electronically ‘‘check-in’’ for office visits, programs, and drug lab testing. In addition, the system properly verifies a participant’s identity at the time of check-in, thereby reducing the risk of inaccurate accounting of an individual’s participation. ROUTINE USES OF RECORDS MAINTAINED IN THE SYSTEM, INCLUDING CATEGORIES OF USERS AND THE PURPOSES OF SUCH USES: CSOSA is not establishing routine uses for the Biometric Verification System at this time; however, CSOSA will make other disclosures generally permitted under 5 U.S.C. 552a(b) of the Privacy Act. system is limited to those CSOSA staff members with appropriate clearances or permissions who have a need to know the information or the need to access the system for the performance of their official duties. Individuals enrolled in the Biometric Verification System cannot access records through the biometric hand reader technology. The records retention schedule (DAA–0562–2012–0002) has been submitted by CSOSA to the National Archives and Records Administration for review and approval. SYSTEM MANAGER(S) AND ADDRESS: Associate Director, Community Supervision Services, Court Services and Offender Supervision Agency, 300 Indiana Avenue NW., Washington, DC 20004. NOTIFICATION PROCEDURE: Inquiries concerning this system should be directed to the Office of the General Counsel, Court Services and Offender Supervision Agency, 633 Indiana Avenue NW., Washington, DC 20004. RECORD ACCESS PROCEDURES: See ‘‘Notification Procedure’’ above. See ‘‘Notification Procedure’’ above. None. RECORD SOURCE CATEGORIES: POLICIES AND PRACTICES FOR STORING, RETREIVING, ACCESSING, RETAINING, AND DISPOSING OF RECORDS IN THE SYSTEM: STORAGE: Records in this system are stored electronically or on paper in secure facilities behind a locked door. The records may be stored on magnetic disc, tape, other digital media, and/or on paper. RETRIEVABILITY: CSOSA staff members are able to search and retrieve the information by a number of personal identifiers: last name, first name, date of birth, Police Department Identification (PDID), PIN, or CSOSA Number. mstockstill on DSK4VPTVN1PROD with NOTICES SAFEGUARDS: Records in this system are safeguarded in accordance with application laws, rules and policies, including federal and all applicable CSOSA automated systems security and access policies. Strict controls have been imposed to minimize the risk of compromising the information that is being stored. Access to the computer system containing the records in this VerDate Mar<15>2010 17:58 Apr 15, 2013 Jkt 229001 The information in the Biometric Verification System comes from one of four sources: (1) Another CSOSA IT system, when an offender is enrolled in or checks-in through the Biometric Verification System; (2) the individual under supervision, when the individual enters his/her PIN and uses his/her right hand for the biometric scan each checkin; (3) generated by the Biometric Verification System, when the system generates verification system generates the Probationer ID (PIN), the date generates the Probationer ID (PIN), the date of check-in, time of check-in, the location of the check-in, and the venue (program attendance, office visit, or drug lab testing; and (4) from information entered by CSOSA staff, to include the capture of the hand biometric (offender’s right hand), recapture of the hand biometric when needed, entry of the biometric by-pass (if needed), and assisting with all checkins by selecting the venue and the hand reader to be used for the check-in. EXEMPTIONS CLAIMED FOR THE SYSTEM: PO 00000 None. Frm 00013 Fmt 4703 Sfmt 4703 Dated: April 10, 2013. Rorey Smith, Deputy General Counsel and Chief Privacy Officer, Court Services and Offender Supervision Agency. [FR Doc. 2013–08884 Filed 4–15–13; 8:45 am] BILLING CODE 3129–04–P DEPARTMENT OF DEFENSE RETENTION AND DISPOSAL: CONTESTING RECORD PROCEDURES: DISCLOSURE TO CONSUMER REPORTING AGENCIES: 22523 Office of the Secretary Meeting of the Uniform Formulary Beneficiary Advisory Panel Department of Defense, Assistant Secretary of Defense (Health Affairs). ACTION: Notice of meeting. AGENCY: SUMMARY: Under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C. Appendix, as amended) and the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended) the Department of Defense (DoD) announces the following Federal Advisory Committee Meeting of the Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as the Panel). DATES: April 25, 2013, from 9:00 a.m. to 1:00 p.m. ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue NW., Washington, DC 20004. FOR FURTHER INFORMATION CONTACT: CDR Joseph Lawrence, DFO, Uniform Formulary Beneficiary Advisory Panel, 4130 Stanley Road, Suite 208, Building 1000, San Antonio, TX 78234–6012, Telephone: (210) 295–1271, Fax: (210) 295–2789. Email Address: Baprequests@ tma.osd.mil. SUPPLEMENTARY INFORMATION: Purpose of Meeting: The Panel will review and comment on recommendations made to the Director of TRICARE Management Activity, by the Pharmacy and Therapeutics Committee, regarding the Uniform Formulary. Meeting Agenda: 1. Sign-In 2. Welcome and Opening Remarks 3. Public Citizen Comments 4. Scheduled Therapeutic Class Reviews (Comments will follow each agenda item) a. Topical Pain Agents b. Pulmonary—2 Agents: COPD c. Anticoagulants d. Designated Newly Approved Drugs in Already-Reviewed Classes e. Pertinent Utilization Management Issues 5. Panel Discussions and Vote E:\FR\FM\16APN1.SGM 16APN1 mstockstill on DSK4VPTVN1PROD with NOTICES 22524 Federal Register / Vol. 78, No. 73 / Tuesday, April 16, 2013 / Notices Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102–3.140 through 102–3.165, and the availability of space, this meeting is open to the public. Seating is limited and will be provided only to the first 220 people signing-in. All persons must sign-in legibly. Administrative Work Meeting: Prior to the public meeting, the Panel will conduct an Administrative Work Meeting from 7:30 a.m. to 9:00 a.m. to discuss administrative matters of the Panel. The Administrative Work Meeting will be held at the Naval Heritage Center, 701 Pennsylvania Avenue NW., Washington, DC 20004. Pursuant to 41 CFR 102–3.160, the Administrative Work Meeting will be closed to the public. Written Statements: Pursuant to 41 CFR 102–3.105(j) and 102–3.140, the public or interested organizations may submit written statements to the membership of the Panel at any time or in response to the stated agenda of a planned meeting. Written statements should be submitted to the Panel’s Designated Federal Officer (DFO). The DFO’s contact information can be obtained from the General Services Administration’s Federal Advisory Committee Act Database at https:// www.fido.gov/facadatabase/public.asp. Written statements that do not pertain to the scheduled meeting of the Panel may be submitted at any time. However, if individual comments pertain to a specific topic being discussed at a planned meeting, then these statements must be submitted no later than 5 business days prior to the meeting in question. The DFO will review all submitted written statements and provide copies to all the committee members. Public Comments: In addition to written statements, the Panel will set aside 1 hour for individuals or interested groups to address the Panel. To ensure consideration of their comments, individuals and interested groups should submit written statements as outlined in this notice; but if they still want to address the Panel, then they will be afforded the opportunity to register to address the Panel. The Panel’s DFO will have a ‘‘Sign-Up Roster’’ available at the Panel meeting for registration on a first-come, first-serve basis. Those wishing to address the Panel will be given no more than 5 minutes to present their comments, and at the end of the 1 hour time period, no further public comments will be accepted. Anyone who signs-up to address the Panel, but is unable to do so due to the time limitation, may submit their comments VerDate Mar<15>2010 19:15 Apr 15, 2013 Jkt 229001 in writing; however, they must understand that their written comments may not be reviewed prior to the Panel’s deliberation. To ensure timeliness of comments for the official record, the Panel encourages that individuals and interested groups consider submitting written statements instead of addressing the Panel. Due to difficulties beyond the control of the Uniform Formulary Beneficiary Advisory Panel or its Designated Federal Officer, the Panel was unable to file a Federal Register notice for the April 25, 2013 meeting of the Uniform Formulary Beneficiary Advisory Panel as required by 41 CFR 102–3.150(a). Accordingly, the Advisory Committee Management Officer for the Department of Defense, pursuant to 41 CFR 102– 3.150(b), waives the 15-calendar day notification requirement. Dated: April 11, 2013. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2013–08859 Filed 4–15–13; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Office of the Secretary [Docket ID: DoD–2013–OS–0077] Privacy Act of 1974; System of Records AGENCY: Defense Intelligence Agency, DoD. Notice to alter a System of Records. ACTION: The Defense Intelligence Agency is proposing to alter a system to its existing inventory of records systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended. DATES: This proposed action will be effective on May 17, 2013 unless comments are received which result in a contrary determination. Comments will be accepted on or before May 16, 2013. ADDRESSES: You may submit comments, identified by docket number and title, by any of the following methods: * Federal Rulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. * Mail: Federal Docket Management System Office, 4800 Mark Center Drive; East Tower, 2nd Floor, Suite 02G09, Alexandria, VA 22350–3100. Instructions: All submissions received must include the agency name and docket number for this Federal Register document. The general policy for SUMMARY: PO 00000 Frm 00014 Fmt 4703 Sfmt 4703 comments and other submissions from members of the public is to make these submissions available for public viewing on the Internet at https:// www.regulations.gov as they are received without change, including any personal identifiers or contact information. Ms. Theresa Lowery at Defense Intelligence Agency, DAN 1–C, 600 MacDill Blvd., Washington, DC 20340–0001 or by phone at (202) 231–1193. SUPPLEMENTARY INFORMATION: The Defense Intelligence Agency system of records notices subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended, have been published in the Federal Register and are available from the address FOR FURTHER INFORMATION CONTACT. The proposed system report, as required by 5 U.S.C. 552a of the Privacy Act of 1974, as amended, was submitted on April 1, 2013, to the House Committee on Oversight and Government Reform, the Senate Committee on Governmental Affairs, and the Office of Management and Budget (OMB) pursuant to paragraph 4c of Appendix I to OMB Circular No. A– 130, ‘‘Federal Agency Responsibilities for Maintaining Records About Individuals, ‘‘dated February 8, 1996 (February 20, 1996, 61 FR 6427). FOR FURTHER INFORMATION CONTACT: Dated: April 1, 2013. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. LDIA 0271 SYSTEM NAME: Investigations and Complaints (June 2, 2010, 75 FR 30791). CHANGES * * * * * SYSTEM LOCATION: Delete entry and replace with ‘‘Defense Intelligence Agency,600 MacDill Blvd., Washington, DC 20340– 0001.’’ CATEGORIES OF INDIVIDUALS COVERED BY THE SYSTEM: Delete entry and replace with ‘‘Current and former civilian, military, or contract personnel and members of the public who file a complaint or who are the subject of an investigation conducted by the agency.’’ CATEGORIES OF RECORDS IN THE SYSTEM: Delete entry and replace with ‘‘Name, Social Security Number (SSN), date of birth, place of birth, telephone number and address if applicable along with E:\FR\FM\16APN1.SGM 16APN1

Agencies

[Federal Register Volume 78, Number 73 (Tuesday, April 16, 2013)]
[Notices]
[Pages 22523-22524]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-08859]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Meeting of the Uniform Formulary Beneficiary Advisory Panel

AGENCY: Department of Defense, Assistant Secretary of Defense (Health 
Affairs).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: Under the provisions of the Federal Advisory Committee Act of 
1972 (5 U.S.C. Appendix, as amended) and the Government in the Sunshine 
Act of 1976 (5 U.S.C. 552b, as amended) the Department of Defense (DoD) 
announces the following Federal Advisory Committee Meeting of the 
Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as 
the Panel).

DATES: April 25, 2013, from 9:00 a.m. to 1:00 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue NW., 
Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: CDR Joseph Lawrence, DFO, Uniform 
Formulary Beneficiary Advisory Panel, 4130 Stanley Road, Suite 208, 
Building 1000, San Antonio, TX 78234-6012, Telephone: (210) 295-1271, 
Fax: (210) 295-2789. Email Address: Baprequests@tma.osd.mil.

SUPPLEMENTARY INFORMATION:
    Purpose of Meeting: The Panel will review and comment on 
recommendations made to the Director of TRICARE Management Activity, by 
the Pharmacy and Therapeutics Committee, regarding the Uniform 
Formulary.
    Meeting Agenda:

1. Sign-In
2. Welcome and Opening Remarks
3. Public Citizen Comments
4. Scheduled Therapeutic Class Reviews (Comments will follow each 
agenda item)
    a. Topical Pain Agents
    b. Pulmonary--2 Agents: COPD
    c. Anticoagulants
    d. Designated Newly Approved Drugs in Already-Reviewed Classes
    e. Pertinent Utilization Management Issues
5. Panel Discussions and Vote


[[Page 22524]]


    Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 
41 CFR 102-3.140 through 102-3.165, and the availability of space, this 
meeting is open to the public. Seating is limited and will be provided 
only to the first 220 people signing-in. All persons must sign-in 
legibly.
    Administrative Work Meeting: Prior to the public meeting, the Panel 
will conduct an Administrative Work Meeting from 7:30 a.m. to 9:00 a.m. 
to discuss administrative matters of the Panel. The Administrative Work 
Meeting will be held at the Naval Heritage Center, 701 Pennsylvania 
Avenue NW., Washington, DC 20004. Pursuant to 41 CFR 102-3.160, the 
Administrative Work Meeting will be closed to the public.
    Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-3.140, 
the public or interested organizations may submit written statements to 
the membership of the Panel at any time or in response to the stated 
agenda of a planned meeting. Written statements should be submitted to 
the Panel's Designated Federal Officer (DFO). The DFO's contact 
information can be obtained from the General Services Administration's 
Federal Advisory Committee Act Database at https://www.fido.gov/facadatabase/public.asp.
    Written statements that do not pertain to the scheduled meeting of 
the Panel may be submitted at any time. However, if individual comments 
pertain to a specific topic being discussed at a planned meeting, then 
these statements must be submitted no later than 5 business days prior 
to the meeting in question. The DFO will review all submitted written 
statements and provide copies to all the committee members.
    Public Comments: In addition to written statements, the Panel will 
set aside 1 hour for individuals or interested groups to address the 
Panel. To ensure consideration of their comments, individuals and 
interested groups should submit written statements as outlined in this 
notice; but if they still want to address the Panel, then they will be 
afforded the opportunity to register to address the Panel. The Panel's 
DFO will have a ``Sign-Up Roster'' available at the Panel meeting for 
registration on a first-come, first-serve basis. Those wishing to 
address the Panel will be given no more than 5 minutes to present their 
comments, and at the end of the 1 hour time period, no further public 
comments will be accepted. Anyone who signs-up to address the Panel, 
but is unable to do so due to the time limitation, may submit their 
comments in writing; however, they must understand that their written 
comments may not be reviewed prior to the Panel's deliberation.
    To ensure timeliness of comments for the official record, the Panel 
encourages that individuals and interested groups consider submitting 
written statements instead of addressing the Panel. Due to difficulties 
beyond the control of the Uniform Formulary Beneficiary Advisory Panel 
or its Designated Federal Officer, the Panel was unable to file a 
Federal Register notice for the April 25, 2013 meeting of the Uniform 
Formulary Beneficiary Advisory Panel as required by 41 CFR 102-
3.150(a). Accordingly, the Advisory Committee Management Officer for 
the Department of Defense, pursuant to 41 CFR 102-3.150(b), waives the 
15-calendar day notification requirement.

    Dated: April 11, 2013.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2013-08859 Filed 4-15-13; 8:45 am]
BILLING CODE 5001-06-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.